“Gas Station Heroin” Fears Grow as States Move to Ban Tianeptine; Health Officials Warn of Deadly, Addictive Effects
Tianeptine—nicknamed “gas station heroin”—is an unapproved antidepressant sold illegally in pills, powders and liquids across the U.S.; it has opioid-like effects, a high overdose risk, and is prompting state bans and federal warnings.
Key takeaways
- Unapproved and dangerous: Tianeptine is not FDA-approved in the U.S. and is sold illegally as supplements and novelty products; see the FDA consumer alert.
- Opioid-like risk: At high doses it activates mu-opioid receptors and can be more potent than morphine, causing respiratory depression, coma and death (NCBI research notes).
- Widespread availability and misleading marketing: Sold under names like Tianaa, Neptune’s Fix and TD Red in stores and online (VCU Health overview).
- Regulatory response: At least 14 states have moved to schedule or ban tianeptine; Connecticut recently banned sale and use and expanded scheduling measures (New Jersey health alert).
Main story
What is tianeptine and why is it called “gas station heroin”?
Tianeptine was originally developed and prescribed in some countries for depression and anxiety at low, controlled doses. In the U.S., however, unapproved versions—often stronger or adulterated—are sold in convenience stores, gas stations, vape shops and online under names such as Tianaa, ZaZa, Neptune’s Fix, Pegasus and TD Red. The drug can produce euphoria at low doses and stimulate mu-opioid receptors at higher doses, leading clinicians and regulators to dub it “gas station heroin” (Mayo Clinic background; FDA consumer alert).
How it affects the body
At low doses, tianeptine may affect serotonin pathways and produce mood-elevating effects. At higher doses it binds mu-opioid receptors—similar to heroin and prescription opioids—causing profound sedation, slowed breathing and the potential for life-threatening overdose. Withdrawal from sustained use produces severe flu-like symptoms (sweating, muscle pain, nausea) and intense cravings. Standard drug screens commonly miss tianeptine, so cases may go undetected (NCBI research notes; Mayo Clinic background).
Health risks and documented harms
Poison control centers and emergency departments report rising calls and severe cases tied to tianeptine use. Notable clusters include New Jersey’s 2024 cluster linked to a product labeled Neptune’s Fix, which involved deaths and critical illnesses. Virginia poison centers logged ICU admissions for toxicity and withdrawal. The Drug Enforcement Administration and clinicians warn misuse can cause respiratory depression, severe sedation and death (FDA consumer alert; New Jersey health alert; VCU Health overview).
Regulatory moves and state actions
Faced with increasing incidents, at least 14 states have moved to classify tianeptine as a Schedule I controlled substance. Connecticut recently banned sale and use and expanded scheduling to include related compounds such as kratom (New Jersey health alert). Connecticut Lt. Gov. Susan Bysiewicz described the changes as necessary to curb addiction and protect children from candy-like flavored products that mislead consumers.
At the federal level, FDA leaders reiterate that tianeptine is unapproved in the U.S. and can be more addictive than morphine at high doses. In May 2025, FDA Commissioner Martin Makary warned of a “dangerous and growing health trend” and urged public awareness to protect young people, comparing delays in recognizing the threat to past struggles with the opioid and vaping crises (FDA consumer alert).
Marketing, availability and deceptive claims
Products are marketed as mood boosters, pain relievers or cognitive enhancers and sold in pill, powder, salt or liquid forms. Some vendors use candy-like flavors that appeal to youth. Those tactics and false labeling have drawn criticism from lawmakers and public health officials. Neptune Resources issued a recall after FDA notices in 2024, yet similar products continue to appear on store shelves and online marketplaces. Lawmakers, including Rep. Frank Pallone, urged convenience-store groups to remove these products (congressional press release; emerging-substances overview).
Expert voices
“Low-dose euphoria stems from serotonin effects, but higher doses stimulate mu-opioid receptors and can suppress breathing — the same mechanism that causes fatal overdoses with heroin and other opioids,” said Dr. Robert Schwaner, vice chair of system clinical affairs at Stony Brook Emergency Medicine.”
Emergency physicians and toxicologists call for national regulation given interstate product flow and risks to youth and people with substance-use disorders (FDA consumer alert).
Public health outreach and treatment resources
Health agencies advise clinicians to consider tianeptine in unexplained opioid-like overdoses, particularly when standard drug screens are negative. People with addiction or exposure to these products can contact SAMHSA’s National Helpline for free, confidential treatment referrals and information 24/7.
Why detection is difficult
Tianeptine commonly slips through routine toxicology tests; specialized assays are required to confirm its presence. The gap in routine testing has hindered accurate prevalence tracking and delayed timely public health responses as poison center calls rose over the past decade (VCU Health overview; FDA consumer alert).
Implications for Utah
Economic impact
Convenience stores, gas stations and vape retailers in Utah could face supply disruptions and compliance costs if further state bans or federal action occur. Retailers should audit inventory and pull unapproved tianeptine products to avoid legal exposure. Consumers should be cautious of low-cost supplements sold without clear labeling (FDA consumer alert).
Political consequences
Utah’s conservative leadership often emphasizes community safety and protecting children; lawmakers may face pressure from public health officials and parents to adopt scheduling, product bans, or stiffer penalties for sellers. A federal Schedule I designation could centralize enforcement and shift the debate from state to national policy (congressional press release).
Social effects
Utah communities with higher substance-use rates or limited treatment access are at particular risk. Candy-like marketing and flavors make these products especially dangerous for youth. School districts, parents and faith-based organizations may ramp up prevention and education efforts. Clinicians and first responders should be alert to opioid-like presentations in young people that do not appear on routine screens (New Jersey health alert).
Cultural relevance
Utah’s strong family networks and community ties can support prevention and recovery. Messaging that emphasizes protecting children and supporting neighbors with addiction may resonate and encourage cross-sector cooperation among law enforcement, schools and churches (SAMHSA’s National Helpline).
Practical applications for residents
- Consumers: Avoid unapproved supplements marketed as mood enhancers or pain relievers.
- Retailers: Remove suspect products and train staff to refuse sales of unapproved tianeptine products.
- Clinicians/first responders: Consider tianeptine in unexplained opioid-like cases and contact state poison control for guidance.
- Help: Anyone struggling with substance use can call SAMHSA’s National Helpline for assistance.
Reporting and sources
This report draws on regulatory alerts, state health notices and clinical summaries from public-health and medical authorities. Key sources include:
- FDA consumer alert
- New Jersey health alert
- VCU Health overview
- Mayo Clinic background
- NCBI research notes
- Congressional press release urging retailer action
- Emerging-substances overview
- SAMHSA’s National Helpline
Officials and clinicians continue to urge caution, reporting and swift action by retailers and lawmakers to keep tianeptine—the so-called gas station heroin—off shelves and away from children and vulnerable people.
